Reversal of intestinal failure-associated liver disease by switching from a combination lipid emulsion containing fish oil to fish oil monotherapy

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 3, 2016, Pages 437-440

  Lee, Sanghoon ^a   Park, Hyo Jung ^a   Yoon, Jihye ^a   Hong, Seul Hee ^a   Oh, Chae Youn ^a   Lee, Suk Koo ^a   Seo, Jeong Meen ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

fish oil; intestinal failure; intestinal failure associated liver disease; intravenous lipid emulsion; parenteral nutrition

Indexed keywords

BILIRUBIN GLUCURONIDE; FISH OIL; LIPID EMULSION; LIPID EMULSION CONTAINING FISH OIL; OMEGAVEN; UNCLASSIFIED DRUG; BILIRUBIN;

ARTICLE; BILE DUCT BYPASS; BILE DUCT STONE; BILIARY TRACT DRAINAGE; BLEEDING; CASE REPORT; CHILD; CHOLEDOCHOTOMY; CHOLESTASIS; COMMON BILE DUCT CYST; COMMON BILE DUCT STONE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; ENTEROPATHY; FEMALE; GASTROSCHISIS; HIRSCHSPRUNG DISEASE; HUMAN; HYPERBILIRUBINEMIA; ILEOSTOMY; INFANT; INTESTINAL DYSMOTILITY; INTESTINAL FAILURE; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; INTESTINE BIOPSY; INTESTINE RESECTION; JEJUNOSTOMY; LIVER DISEASE; MALE; MEGACYSTIS MICROCOLON INTESTINAL HYPOPERISTALSIS SYNDROME; MONOTHERAPY; PARENTERAL NUTRITION; PRIORITY JOURNAL; T TUBE; TREATMENT DURATION; ABNORMALITIES; ABNORMALITIES, MULTIPLE; BLADDER; COLON; COMPLICATION; INTESTINAL PSEUDO-OBSTRUCTION; LIVER DISEASES; METABOLISM; PROCEDURES;

ABNORMALITIES, MULTIPLE; BILIRUBIN; CHOLESTASIS; COLON; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; GASTROSCHISIS; HIRSCHSPRUNG DISEASE; HUMANS; HYPERBILIRUBINEMIA; INFANT; INTESTINAL PSEUDO-OBSTRUCTION; LIVER DISEASES; MALE; PARENTERAL NUTRITION; URINARY BLADDER;

EID: 84959278871     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114567200     Document Type: Article

References (27)

1. Buchman AL,. Complications of long-term home total parenteral nutrition: their identification, prevention and treatment. Dig Dis Sci. 2001; 46: 1-18.
2. Buchman A,. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2002; 26: S43-S48.
3. Zambrano E, El-Hennawy M, Ehrenkranz RA, Zelterman D, Reyes-Mugica M,. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol. 2004; 7: 425-432.
4. Kelly DA,. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition. 1998; 14: 153-157.
5. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK,. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol. 2007; 27: 284-290.
6. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM,. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005; 40: 755-762.
7. Moss RL, Amii LA,. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg. 1999; 8: 140-147.
8. Cole CR, Frem JC, Schmotzer B, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr. 2010; 156: 941-947.e1.
9. Rayyan M, Devlieger H, Jochum F, Allegaert K,. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012; 36: 81S-94S.
10. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M,. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009; 33: 541-547.
11. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009; 66: 698-703.
12. Calkins KL, Dunn JC, Shew SB, et al. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil. JPEN J Parenter Enteral Nutr. 2013; 38 (6): 682-692.
13. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006; 118: e197-e201.
14. Nandivada P, Chang MI, Potemkin AK, et al. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy [published online December 26, 2013]. Ann Surg.
15. Fleith M, Clandinin MT,. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr. 2005; 45: 205-229.
16. Innis SM,. Fatty acids and early human development. Early Hum Dev. 2007; 83: 761-766.
17. Clayton PT, Whitfield P, Iyer K,. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998; 14: 158-164.
18. Carter BA, Shulman RJ,. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2007; 4: 277-287.
19. Dichtl W, Ares MP, Jonson AN, et al. Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism. 2002; 51: 327-333.
20. Park HJ, Lee YW, Hennig B, Toborek M,. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr Cancer. 2001; 41: 126-134.
21. Camandola S, Leonarduzzi G, Musso T, et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun. 1996; 229: 643-647.
22. Chen MF, Lee YT, Hsu HC, Yeh PC, Liau CS, Huang PC,. Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits. Int J Cardiol. 1992; 36: 297-304.
23. Lee S, Gura KM, Kim S, Arsenault DA, Bistrian BR, Puder M,. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract. 2006; 21: 323-341.
24. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L,. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010; 51: 514-521.
25. Kim MJ, Bae HJ, Cho YS, Kim GS,. Effects of SMOFlipid on prophylaxis of cholestasis in premature very low birth weight infants. JKSPEN. 2013; 5: 67-75.
26. Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE,. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with omega-6/9 lipid emulsions. JPEN J Parenter Enteral Nutr. 2012; 36: 587-595.
27. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW,. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009; 48: 209-215.